Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details

v3.22.2.2
Balance Sheet Details
3 Months Ended
Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details

Note 4—Balance Sheet Details

 

Property and Equipment

 

Property and equipment, net, is comprised of the following:

 

October 31, 2022 July 31, 2022
Equipment and furniture $ 1,944,540 $ 1,944,540
Computer software 109,242 109,242
Leasehold improvements 32,651 32,651
Construction in progress 446,367 446,367
Property and equipment, gross 2,532,800 2,532,800
Accumulated depreciation and amortization (1,599,099 ) (1,554,186 )
Total $ 933,701 $ 978,614

 

Depreciation and amortization expense recorded for the three months ended October 31, 2022 was approximately $45,000.

 

Depreciation and amortization expense recorded for the three months ended October 31, 2021 was approximately $47,000.

 

Intangible Assets

 

Intangible assets, net, is comprised of the following:

 

October 31, 2022 July 31, 2022
License $ 495,000 $ 495,000
Accumulated amortization (133,941 ) (116,471 )
Total $ 361,059 $ 378,529

 

In November 2020, the Company licensed generator technology for use in its clinical trials and other research and development efforts. Unless earlier terminated, the term of the license agreement will remain in effect for 85 months. The Company has determined that the license has alternative future uses in research and development projects. The value of the acquired license is recorded as an intangible asset with amortization over the estimated useful life of 85 months.

 

 

 

Intangible asset amortization expense recorded for the three months ended October 31, 2022 was approximately $17,000.

 

Intangible asset amortization expense recorded for the three months ended October 31, 2021 was approximately $17,000.

 

At October 31, 2022, the estimated amortization expense by fiscal year based on the current carrying value of intangible assets is as follows:

 

 

Years ending July 31,
2023 – the remainder of the fiscal year $ 52,412
2024 69,882
2025 69,882
2026 69,882
2027 69,882
Thereafter 29,119
Total $ 361,059

 

Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities are comprised of the following:

 

October 31, 2022 July 31, 2022
Research and development costs $ 3,402,401 $ 3,210,627
Professional services fees 1,319,890 877,411
Other 80,165 120,184
Total $ 4,802,456 $ 4,208,222

 

Accrued Compensation

 

Accrued compensation is comprised of the following:

 

 

October 31, 2022 July 31, 2022
Accrued payroll $ 208,781 $ 311,662
401K payable 15,579 7,333
Accrued severance 244,258 57,982
Total $ 468,618 $ 376,977